tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders StocksMarket MoversTipRanks 50 IndexAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Research Tools
Trending StocksCompare StocksCompare ETFsTrump Dashboard
New
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksFDA CalendarMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Trending News
More News >
Education
Personal FinanceHow To Use TipRanksTipRanks LabsGlossaryFAQs
About Us
About TipRanksContact UsReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News Wire
Follow Us
TOOLS
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Market Movers
Compare stocks
Compare ETFs
Notification Center
News
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
AI Analyst Top Stocks
New
Top Insiders Stocks
Compare Stocks
Compare ETFs
Trending Stocks
Daily Analyst Ratings
Daily Insiders Trades
Dividend Stocks
ETF Center
Top Gainers/losers/active ETFs
Trump Dashboard
New
Dividend Calculator
Options Profit Calculator
Dollar Cost Averaging
Compound Interest Calculator
Mortgage Calculator
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
FDA Calendar
Market Holidays
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
Top Gainers
Top Losers
Most Active
Premarket
After-hours
Private Companies
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Real Estate
Top Online Brokers
Enterprise Solutions
Plans & Pricing
Education
How To Use TipRanks
TipRanks Labs
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us
STOCKS
SPY
QQQ
AAPL
NVDA
TSLA
AMZN
BABA
Advertisement
Advertisement

VRDN Stock Latest News

3 Stocks Flashing Strong Buy Signals, Backed by Technical Analysis
Market News3 Stocks Flashing Strong Buy Signals, Backed by Technical Analysis
3d ago
NGD
WVE
Viridian Therapeutics: Strong Market Position and Promising Catalysts Justify Buy Rating
PremiumRatings
Viridian Therapeutics: Strong Market Position and Promising Catalysts Justify Buy Rating
4d ago
VRDN
Viridian Therapeutics Positioned for Growth in TED Market Amidst Competitive Setbacks
PremiumRatings
Viridian Therapeutics Positioned for Growth in TED Market Amidst Competitive Setbacks
5d ago
VRDN
Argenx exit leaves more room for Viridian in TED, says Truist
PremiumThe Fly
Argenx exit leaves more room for Viridian in TED, says Truist
5d ago
ARGX
VRDN
Viridian Therapeutics rises 5.0%
PremiumThe Fly
Viridian Therapeutics rises 5.0%
5d ago
VRDN
Viridian Therapeutics: Positioned for Growth with Promising Pipeline and Strong Financials
PremiumRatingsViridian Therapeutics: Positioned for Growth with Promising Pipeline and Strong Financials
10d ago
VRDN
Viridian Therapeutics initiated with an Outperform at William Blair
Premium
The Fly
Viridian Therapeutics initiated with an Outperform at William Blair
17d ago
VRDN
Viridian Therapeutics initiated with an Outperform at William Blair
Premium
The Fly
Viridian Therapeutics initiated with an Outperform at William Blair
17d ago
VRDN
Viridian Therapeutics initiated with a Buy at Truist
PremiumThe Fly
Viridian Therapeutics initiated with a Buy at Truist
26d ago
VRDN
Promising Developments and Market Potential Drive Buy Rating for Viridian Therapeutics
PremiumRatings
Promising Developments and Market Potential Drive Buy Rating for Viridian Therapeutics
29d ago
VRDN
Viridian Therapeutics Advances Toward Profitability with Strategic Moves
PremiumCompany Announcements
Viridian Therapeutics Advances Toward Profitability with Strategic Moves
1M ago
VRDN
Viridian Therapeutics price target raised to $45 from $41 at RBC Capital
PremiumThe Fly
Viridian Therapeutics price target raised to $45 from $41 at RBC Capital
1M ago
VRDN
Viridian Therapeutics price target raised to $40 from $30 at Goldman Sachs
PremiumThe FlyViridian Therapeutics price target raised to $40 from $30 at Goldman Sachs
1M ago
VRDN
Viridian Therapeutics: Promising Future with Strategic Trials and Financial Stability
Premium
Ratings
Viridian Therapeutics: Promising Future with Strategic Trials and Financial Stability
1M ago
VRDN
Viridian Therapeutics reports Q3 EPS (34c), consensus (94c)
Premium
The Fly
Viridian Therapeutics reports Q3 EPS (34c), consensus (94c)
1M ago
VRDN
Viridian Therapeutics: Promising Future with Strategic Advancements and Financial Backing
PremiumRatings
Viridian Therapeutics: Promising Future with Strategic Advancements and Financial Backing
2M ago
VRDN
Viridian Therapeutics: Promising Prospects with Innovative TED Treatments and Financial Stability Justify Buy Rating
PremiumRatings
Viridian Therapeutics: Promising Prospects with Innovative TED Treatments and Financial Stability Justify Buy Rating
2M ago
VRDN
Viridian Therapeutics submits BLA to the FDA for veligrotug
PremiumThe Fly
Viridian Therapeutics submits BLA to the FDA for veligrotug
2M ago
VRDN
Viridian Therapeutics’ Promising Phase 3 Trial for Thyroid Eye Disease
PremiumCompany Announcements
Viridian Therapeutics’ Promising Phase 3 Trial for Thyroid Eye Disease
2M ago
VRDN
Viridian Therapeutics Advances VRDN-003 Study for Thyroid Eye Disease
PremiumCompany AnnouncementsViridian Therapeutics Advances VRDN-003 Study for Thyroid Eye Disease
2M ago
VRDN
Strategic Financial Maneuvers and Key Milestones Position Viridian Therapeutics for Growth: A Buy Rating by Laura Chico
Premium
Ratings
Strategic Financial Maneuvers and Key Milestones Position Viridian Therapeutics for Growth: A Buy Rating by Laura Chico
2M ago
VRDN
Viridian Therapeutics Announces Stock Sale Agreement
Premium
Company Announcements
Viridian Therapeutics Announces Stock Sale Agreement
2M ago
8K
VRDN

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >